Replimune (REPL) Change in Account Payables (2017 - 2026)
Replimune (REPL) reported Change in Account Payables of $956000.0 for Q1 2026, down 81.76% on a YoY basis from $5.2 million in Q1 2025, and up 230.96% sequentially from -$730000.0 in Q4 2025.
Replimune (REPL) Change in Account Payables (2017 - 2026) Analysis & Trends
Replimune (REPL) has 10 years of Change in Account Payables data on file, last reported at $956000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 81.76% year-over-year to $956000.0; the trailing twelve-month figure through Mar 2026 stood at -$4.9 million (down 149.68% YoY), and the FY2026 full-year result was -$4.9 million, down 149.68% from the prior year.
- Change in Account Payables rose to $956000.0 in Q1 2026, from -$730000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $7.5 million in Q3 2024 to a low of -$8.9 million in Q3 2025.
- A 5-year average of $242000.0 and a median of -$213000.0 in 2023 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables tumbled 476.92% in 2022 and jumped 3604.23% in 2024, its largest moves.
- Tracing REPL's Change in Account Payables over 5 years: stood at -$341000.0 in 2022, then tumbled by 39.59% to -$476000.0 in 2023, then slumped by 141.39% to -$1.1 million in 2024, then jumped by 36.47% to -$730000.0 in 2025, then jumped by 230.96% to $956000.0 in 2026.
- Business Quant data shows REPL's Change in Account Payables at $956000.0 in Q1 2026, -$730000.0 in Q4 2025, and -$8.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - | 956,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 956,000.00 |
| Mar 31, 2026 | 956,000.00 |
| Dec 31, 2025 | -730,000.00 |
| Dec 31, 2025 | -730,000.00 |
| Sep 30, 2025 | -8.93 Mn |
| Sep 30, 2025 | -8.93 Mn |
| Jun 30, 2025 | 3.77 Mn |
| Jun 30, 2025 | 3.77 Mn |
| Mar 31, 2025 | 5.24 Mn |
| Mar 31, 2025 | 5.24 Mn |
| Dec 31, 2024 | -1.15 Mn |
| Dec 31, 2024 | -1.15 Mn |
| Sep 30, 2024 | 7.46 Mn |
| Sep 30, 2024 | 7.46 Mn |
| Jun 30, 2024 | -1.62 Mn |
| Jun 30, 2024 | -1.62 Mn |
| Mar 31, 2024 | -1.29 Mn |
| Mar 31, 2024 | -1.29 Mn |
| Dec 31, 2023 | -476,000.00 |
| Dec 31, 2023 | -476,000.00 |